Rituximab Plus Chemotherapy Provides No Clinical Benefit in a Peripheral T-Cell Lymphoma not Otherwise Specified with Aberrant Expression of CD20 and CD79a: A Case Report and Review of the Literature

Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) is the most common entity of mature T-cell neoplasms. PTCL-NOS generally has an aggressive behavior and is often refractory to standard therapy. Only a few cases of PTCL with aberrant expression of B-cell antigens have been reported so f...

Descripción completa

Detalles Bibliográficos
Autores principales: Mangogna, Alessandro, Cox, Maria Christina, Ruco, Luigi, Lopez, Gianluca, Belmonte, Beatrice, Di Napoli, Arianna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344438/
https://www.ncbi.nlm.nih.gov/pubmed/32466492
http://dx.doi.org/10.3390/diagnostics10060341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344438/
https://www.ncbi.nlm.nih.gov/pubmed/32466492
http://dx.doi.org/10.3390/diagnostics10060341

Ejemplares similares